Nutritional management of Crohn’s disease

Therapeutic Advances in Gastroenterology

Volumn 6, Issue 3, 2013, Pages 231-242

  Donnellan, Clare F ^a   Yann, Lee H ^b   Lal, Simon ^c  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b NORTH SHORE HOSPITAL   (New Zealand)

^c SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Crohn s disease; enteral nutrition; intestinal failure; micronutrient deficiency; parenteral nutrition; protein energy malnutrition

Indexed keywords

EID: 84993728801     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X13477715     Document Type: Review

References (98)

1. Abitbol V. Roux C. Chaussade S. Guillemant S. Kolta S. Dougados M. et al. (1995) Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108: 417–422.
2. Afzal N. Davies S. Paintin M. Arnaud-Battandier F. Walker-Smith J. Murch S. et al. (2009) The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther 30: 501–507
3. Afzal N. van der Zaag-Loonen H. Arnaud-Battandier F. Davies S. Murch S. Derkx B. et al. (2004) Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther 20: 167–172
4. Aghdassi E. Wendland B. Stapleton M. Raman M. Allard J. (2007) Adequacy of nutritional intake in a Canadian population of atients with Crohn's disease. J Am Diet Assoc 107: 1575–1580.
5. Aiges H. Markowitz J. Rosa J. Daum F. (1989) Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease. Gastroenterology 97: 905–910.
6. Anstee Q. Forbes A. (2000) The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's disease. Eur J Gastroenterol Hepatol 12: 1089–1093.
7. Belli D. Seidman E. Bouthillier L. Weber A. Roy C. Pletincx M. et al. (1988) Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 94: 603–610.
8. Bjarnason I. Macpherson A. Mackintosh C. (1997) Reduced bone density in patients with inflammatory bowel disease Gut 40: 228–233.
9. Borrelli O. Cordischi L. Cirulli M. Paganelli M. Labalestra V. Uccini S. et al. (2006) Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 4: 744–753.
10. Bousvaros A. Zurakowski D. Duggan C. Law T. Rifai N. Goldberg N. et al. (1998) Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr 26: 129–135.
11. Buchanan E. Gaunt W. Cardigan T. Garrick V. McGrogan P. Russell R. (2009) The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Alim Phar Ther 30: 501–507.
12. Cabre E. Gassull M. (2001) Nutrition in inflammatory bowel disease: impact on disease and therapy. Curr Opin Gastroenterol 17: 342–349.
13. Cairns S. Scholefield J. Steele R. Dunlop M. Thomas H. Evans G. et al. (2010) Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59: 666–689.
14. Christakos S. DeLuca H. (2011) Minireview: vitamin D: is there a role in extraskeletal health? Endocrinology 152: 2930–2936.
15. Compston J. Judd D. Crawley E. Evans W. Evans C. Church H. et al. (1987) Osteoporosis in patients with inflammatory bowel disease. Gut 28: 410–415.
16. Cosgrove M. Jenkins H. (1997) Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease. Arch Dis Child 76: 141–143.
17. Cravo M. Guerreiro C. dos Santos P. Brito M. Ferreira P. Fidalgo C. et al. (2010) Risk factors for metabolic bone disease in Crohn's disease patients. Inflamm Bowel Dis 16: 2117–2124.
18. Dear K. Compston J. Hunter J. (2001) Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clin Nutr 20: 541–546.
19. Dieleman L. Heizer W. (1998). Nutritional issues in inflammatory bowel disease. Gastroenterol Clin North Am 27: 435–451.
20. Duerksen D. Fallows G. Bernstein C. (2006). Vitamin B 12 malabsorption in patients with limited ileal resection. Nutrition 22: 1210–1213.
21. Elia M. (2003) Screening for Malnutrition: A Multidisciplinary Responsibility. Development and Use of the Malnutrition Universal Screening Tool (MUST) for Adults. Malnutrition Advisory Group (MAG), BAPEN.
22. Elsborg L. Larsen L. (1979) Folate deficiency in chronic inflammatory bowel diseases. Scand J Gastroenterol 14: 1019–1024.
23. Esaki M. Matsumoto T. Nakamura S. Yada S. Fujisawa K. Jo Y. et al. (2006) Factors affecting recurrence in patients with Crohn's disease under nutritional therapy. Dis Colon Rectum 49: S68–S74.
24. Feagan B. Sandborn W. Mittmann U. Bar-meir S. D'Haens G. Bradette M. et al. (2008) Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials. JAMA 299: 1690–1697.
25. Gasche C. Berstad A. Befrits R. Beglinger C. Dignass A. Erichsen K. et al. (2007) Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 13: 1545–1553.
26. Gassull M. Abad A. Cabré E. González-Huix F. Giné J. Dolz C. (1986) Enteral nutrition in inflammatory bowel disease. Gut 27: 76–80.
27. Gassull M. Fernández-Bañares F. Cabré E. Papo M. Giaffer M. Sánchez-Lombraña J. et al. (2002) Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 51: 164–168.
28. Gearry R. Irving P. Barrett J. Nathan D. Shepherd S. Gibson P. (2009) Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease a pilot study. J Crohns Colitis 3: 8–14.
29. Geerling B. Badart-Smook A. Stockbrügger R. Brummer R. (1998) Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 67: 919–926.
30. Gerasimidis K. McGrogan P. Edwards C. (2011) The aetiology and impact of malnutrition in paediatric Crohn's disease. J Hum Nut Diet 24: 313–26.
31. Gibson P. Shepherd S. (2010) Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 25: 252–258.
32. Gisbert J. Bermejo F. Pajares R. Pérez-Calle J. Rodríguez M. Algaba A. et al. (2009) Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 15: 1485–1491.
33. Gisbert J. Gomollon F. (2008) Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 103: 1299–1307.
34. Goh J. O'Morain C. (2003) Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 17: 207–320.
35. Grogan J. Casson D. Terry A. Burdge G. El-Matary W. Dalzell A. (2012) Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double blind randomized controlled trial with two years follow up. Inflamm Bowel Dis 18: 246–253.
36. Han P. Burke A. Baldassano R. Rombeau J. Lichtenstein G. (1999) Nutrition and inflammatory bowel disease. Gastroenterol Clin North Am 28: 423–443.
37. Harries A. Jones L. Danis V. Fifield R. Heatley R. Newcombe R. et al. (1983) Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet 1: 887–890.
38. Harries A. Rhodes J. (1985). Undernutrition in Crohn's disease: an anthropometric assessment. Clin Nutr 4: 87–89.
39. Headstrom P. Rulyak S. Lee S. (2008) Prevalence of and risk factors for vitamin B 12 deficiency in patients with Crohn's disease. Inflamm Bowel Dis 14: 217–223.
40. Hoffbrand A. Stewart J. Booth C. Mollin D. (1968) Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J 2: 71–75.
41. Hou J. Abraham B. El-Serag H. (2011) Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106: 563–573.
42. IBD Standards Group (2009) Quality Care: Service Standards for the Healthcare of People Who Have Inflammatory Bowel Disease (IBD). Available at: http://www.ibdstandards.org.uk/ibd-standards.asp (accessed 23 January 2013).
43. Johnson T. MacDonald S. Hill S. Thomas A. Murphy M. (2006) Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 55: 356–361
44. Jorgensen R. Lindor K. Sartin J. LaRusso N. Wiesner R. (1995) Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. J Clin Gastroenterol 20: 215–219.
45. Klaus J. Armbrecht G. Steinkamp M. Brückel J. Rieber A. Adler G. et al. (2002) High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 51: 654–658.
46. Koga H. Iida M. Aoyagi K. Matsui T. Fujishima M. (1993) Long-term efficacy of low residue diet for the maintenance of remission in patients with Crohn's disease. Nihon Shokakibyo Gakkai Zasshi 90: 2882–2888.
47. Kuriyama M. Kato J. Morimoto N. (2009) Enteral nutrition improves health-related quality of life in Crohn's disease patients with long disease duration. Hepatogastroenterology 56: 321–327.
48. Kuwabara A. Tanaka K. Tsugawa N. Nakase H. Tsuji H. Shide K. et al. (2009) High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 20: 935–942.
49. Lal S. Teubner A. Shaffer J. (2006). Review article: intestinal failure. Aliment Pharmacol Ther 24: 19–31.
50. Lashner B. Provencher K. Seidner D. Knesebeck A. Brzezinski A. (1997) The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112: 29–32.
51. Lochs H. Dejong C. Hammarqvist F. Hebuterne X. Leon-Sanz M. Schütz T. et al. (2006) ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr 25: 260–274.
52. Logan R. Gillon J. Ferrington C. Ferguson A. (1981) Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut 22: 383–387.
53. MacLean C. Mojica W. Newberry S. Pencharz J. Garland R. Tu W. et al. (2005) Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 82: 611–619.
54. Mijac D. Jankovic G. Jorga J. Krstic M. (2010). Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Int Med 21: 315–319.
55. Mowat C. Cole A. Windsor A. Ahmad T. Arnott I. Driscoll R. et al. (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60: 571–607.
56. NICE (2012) Crohn's Disease – Management in children, adults and young people NCG152. Available at: http://www.nice.org.uk/nicemedia/live/13936/61001/61001.pdf
57. Nguyen G. Munsell M. (2008) Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 14: 1105–1111.
58. O'Keefe S. Buchman A. Fishbein T. Jeejeebhoy K. Jeppesen P. Shaffer J. (2006) Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 4: 6–10.
59. Oldenburg B. Fijnheer R. van der Griend R. vanBerge-Henegouwen G. Koningsberger J. (2000) Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 95: 2825–2830.
60. O'Sullivan M. O'Morain C. (1998) Nutritional therapy in Crohn's disease. Inflamm Bowel Dis 4: 45–53.
61. Paganelli M. Albanese C. Borrelli O. Civitelli F. Canitano N. Viola F. et al. (2007) Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 13: 416–423.
62. Phelip J. Ducros V. Faucheron J. Flourie B. Roblin X. (2008) Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis 14: 242–248.
63. Pigot F. Roux C. Chaussade S. Hardelin D. Pelleter O. Du Puy Montbrun T. et al (1992) Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 37: 1396–1403.
64. Pons R. Whitten K. Woodhead H. Leach S. Lemberg D. Day A. (2009) Dietary intakes of children with Crohn's disease. Br J Nutr 102: 1052–1057.
65. Rigaud D. Angel L. Cerf M. Carduner M. Melchior J. Sautier C. et al. (1994) Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr 60: 775–781.
66. Rimon E. Kagansky N. Kagansky M. Mechnick L. Mashiah T. Namir M. et al. (2005) Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 118: 1142–1147.
67. Riordan A. Hunter J. Cowan R. Crampton J. Davidson A. Dickinson R. et al. (1993) Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 342: 1131–1134.
68. Robinson R. al-Azzawi F. Iqbal S. Kryswcki T. Almond L. Abrams K. et al. (1998) Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci 43: 2500–2506.
69. Royal College of Physicians (2011) UK Inflammatory Bowel Disease Audit 3rd Round. Available at: http://www.rcplondon.ac.uk/sites/default/files/report-of-the-results-for-the-national-organisational-audit-of-adult-inflammatory-bowel-disease-services-in-the-uk-2011.pdf (accessed 23 January 2013).
70. Rubio A. Pigneur B. Garnier-Lengline H. Talbotec C. Schmitz J. Canioni D. et al. (2011) The efficacy of exclusive nutrition therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Alim Pharm Ther 33: 1332–1339.
71. Rumi G. Jr Szabó I. Vincze A. Matus Z. Tóth G. Mózsik G. (2000) Decrease of serum carotenoids in Crohn's disease. J Physiol Paris 94: 159–161.
72. Russell C. Elia M. (2011) Nutrition Screening Survey in the UK and Republic of Ireland in 2010. Report, BAPEN, UK, February.
73. Rutgeerts P. (2001). Review article: the limitations of corticosteroid therapy in Crohn's disease. Aliment Pharmacol Ther 15: 1515–1525.
74. Rutgeerts P. Geboes K. Vantrappen G. Beyls J. Kerremans R. Hiele M. (1990) Predictability of post operative course of Crohn's disease. Gastroenterology 99: 956–963.
75. Sanderson I. Croft N. (2005). The anti-inflammatory effects of enteral nutrition. J Parenter Enteral Nutr 29(4 Suppl.): S134–S138.
76. Schoon E. Geerling B. van Dooren I. Schurgers L. Vermeer C. Brummer R. et al. (2001) Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharm Ther 15: 783–792.
77. Staudacher H. Whelan K. Irving P. Lomer M. (2011) Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 24: 487–495.
78. Stein J. Bager P. Befrits R. Danese S. Gasche C. Magro F. et al. (2011) Current European practice in diagnosis and treatment of IBD-associated anaemia. J Crohns Colitis 5: S45.
79. Stewart M. (2011) Physician Attitudes and Practices of Enteral Nutrition as Primary Treatment of Paediatric Crohn's Disease in North America. J Pediatr Gastroenterol Nutr 52: 38–42.
80. Takagi S. Utsunomiya K. Kuriyama S. Yokoyama H. Takahashi S. Iwabuchi M. et al. (2006) Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 24: 1333–1340.
81. Takagi S. Utsunomiya K. Kuriyama S. Yokoyama H. Takahashi S. Umemura K. et al. (2009) Quality of life of patients and medical cost of “half elemental diet” as maintenance therapy for Crohn's disease: Secondary outcomes of a randomised controlled trial. Dig Liver Dis 41: 390–394.
82. Teahon K. Smethurst P. Pearson M. Levi A. Bjarnason I. (1991) The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology 101: 84–89.
83. Triantafillidis J. Stamataki A. Gikas A. Sklavaina M. Mylonaki M. Georgopoulos F. et al. (2006) Beneficial effect of a polymeric feed, rich in TGF-β, on adult patients with active Crohn's disease: a pilot study. Ann Gastroenterol 19: 77–81
84. Turner D. Zlotkin S. Shah P. Griffiths A. (2009) Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (1): CD006320. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19160277 (accessed January 2012).
85. van Gossum A. Cabre E. Hebuterne X. Jeppesen P. Krznaric Z. Messing B. et al. (2009) ESPEN guidelines on parenteral nutrition: gastroenterology. Clin Nutr 28: 415–427.
86. Verma S. Holdsworth C. Giaffer M. (2001) Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scand J Gastroenterol 36: 383–388.
87. Verma S. Kirkwood B. Brown S. Giaffer M. (2000). Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis 32: 769–774.
88. Voitk A. Echave V. Feller J. Brown R. Gurd F. (1973). Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg 107: 329–333.
89. Wall R. Ross R. Fitzgerald G. Stanton C. (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68: 280–289.
90. Wilschanski M. Sherman P. Pencharz P. Davis L. Corey M. Griffiths A. (1996) supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38: 543–548.
91. Winitz M. Graff J. Gallagher N. Narkin A. Seedman D. (1965) Evaluation of chemical diets as nutrition for man-in-space. Nature 205: 741–743.
92. Woodcock N. Zeigler D. Palmer M. Buckley P. Mitchell C. MacFie J. (2001) Enteral versus parenteral nutrition: a pragmatic study. Nutrition 17: 1–12.
93. Woolner J. Parker T. Kirby G. Hunter J. (1998) The development and evaluation of a diet for maintaining remission in Crohn's disease. J Hum Nutr Diet 11: 1–11.
94. Yakut M. Ustün Y. Kabaçam G. Soykan I. (2010) Serum vitamin B 12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 21: 320–323.
95. Yamamoto T. Nakahigashi M. Umegae S. Kitagawa T. Matsumoto K. (2005) Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 11: 580–588.
96. Yamamoto T. Nakahigashi M. Umegae S. Kitagawa T. Matsumoto K. (2006) Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 25: 67–72.
97. Yamamoto T. Nakahigashi M. Umegae S. Matsumoto K. (2010) Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn's disease. J Gastroenterol 45: 24–29.
98. Zachos M. Tondeur M. Griffiths A. (2007) Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev (1): CD000542. Available at: http://www2.cochrane.org/reviews/en/ab000542.html (accessed 23 January 2013).